19.12

0.78% -0.15

After Hours: 18.90 -0.22 -1.15%

Fulgent Genetics Inc (FLGT)

Overview News Price History Option Chain Financials Discussions Forecast

Fulgent Genetics Inc stock is traded at $19.12, with a volume of 216.71K. It is down -0.78% in the last 24 hours and down -7.59% over the past month. Fulgent Genetics Inc is a technology company that focuses on genetic testing to provide physicians with clinically actionable diagnostic information. The company is engaged in laboratory services business and a therapeutic development business. The laboratory services business which generates key revenue includes, technical laboratory services and professional interpretation of laboratory results by licensed physicians. Its therapeutic development business is focused on developing drug candidates for treating a broad range of cancers. The geographical segments are the United States, which generates the vast majority of the revenue; and Foreign.

Previous Close:

$19.27

Open:

$19.2

24h Volume:

216.71K

Relative Volume:

0.71

Market Cap:

$582.08M

Revenue:

$290.71M

Net Income/Loss:

$-163.43M

P/E Ratio:

-3.4891

EPS:

-5.48

Net Cash Flow:

$11.70M

1W Performance:

-0.88%

1M Performance:

-7.59%

6M Performance:

+11.62%

1Y Performance:

-8.74%

1-Day Range:

$18.82

$19.30

1-Week Range:

$18.82

$19.96

52-Week Range:

$14.76

$25.11

Fulgent Genetics Inc Stock (FLGT) Company Profile

Name

Fulgent Genetics Inc

Sector

Healthcare (1162)

Industry

Diagnostics & Research (54)

Phone

626-350-0537

Address

4399 SANTA ANITA AVE, EL MONTE

Employee

1,313

Twitter

@FulgentGenetics

Next Earnings Date

2025-05-02

Latest SEC Filings

FLGT's Discussions on Twitter

Compare FLGT with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
FLGT Fulgent Genetics Inc	19.12	587.26M	290.71M	-163.43M	11.70M	-5.48
TMO Thermo Fisher Scientific Inc	425.34	158.06B	42.90B	6.52B	6.72B	17.05
DHR Danaher Corp	197.75	142.87B	23.82B	3.77B	4.90B	5.15
IDXX Idexx Laboratories Inc	531.42	43.87B	3.93B	894.97M	837.70M	10.82
A Agilent Technologies Inc	120.08	33.87B	6.63B	1.17B	1.19B	4.05
IQV Iqvia Holdings Inc	160.13	28.10B	15.50B	1.33B	2.16B	7.34

Fulgent Genetics Inc Stock (FLGT) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Dec-07-23	Initiated	UBS	Neutral
Dec-08-22	Downgrade	Piper Sandler	Overweight → Neutral
Nov-18-22	Initiated	Raymond James	Outperform
Aug-25-22	Initiated	Credit Suisse	Outperform
Feb-04-22	Resumed	Piper Sandler	Overweight
Aug-05-21	Resumed	Credit Suisse	Underperform
Jan-08-21	Downgrade	Credit Suisse	Neutral → Underperform
Nov-24-20	Downgrade	BTIG Research	Buy → Neutral
Aug-20-20	Initiated	Oppenheimer	Outperform
May-29-20	Initiated	BTIG Research	Buy
Nov-05-19	Upgrade	Piper Jaffray	Neutral → Overweight
Mar-01-18	Downgrade	Piper Jaffray	Overweight → Neutral
Nov-07-17	Downgrade	Raymond James	Outperform → Mkt Perform

View All

Fulgent Genetics Inc Stock (FLGT) Latest News

04:09 AM

Why Fulgent Genetics Inc. stock attracts strong analyst attentionInsider Strategy Insight - beatles.ru

04:09 AM

Jul 12, 2025

Fulgent Genetics, Inc. (NASDAQ:FLGT) Shares Bought by Peapod Lane Capital LLC - MarketBeat

Jul 12, 2025

Jul 10, 2025

Fulgent to Announce Second Quarter 2025 Financial Results on Friday, August 1, 2025 - BioSpace

Jul 10, 2025

Jul 09, 2025

Fulgent Genetics, Inc. (NASDAQ:FLGT) Shares Acquired by GAMMA Investing LLC - Defense World

Jul 09, 2025

iRhythm Technologies (NASDAQ:IRTC) & Fulgent Genetics (NASDAQ:FLGT) Financial Review - Defense World

Jul 09, 2025

Jul 05, 2025

(FLGT) Long Term Investment Analysis - news.stocktradersdaily.com

Jul 05, 2025

Jun 30, 2025

Bragar Eagel & Squire, P.C. Is Investigating GoHealth, - GlobeNewswire

Jun 30, 2025

Jun 26, 2025

Rhumbline Advisers Sells 34,049 Shares of Fulgent Genetics, Inc. (NASDAQ:FLGT) - MarketBeat

Jun 26, 2025

Jun 23, 2025

Fulgent Genetics: A 'Sum Of The Parts' Story (NASDAQ:FLGT) - Seeking Alpha

Jun 23, 2025

Jun 22, 2025

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Fulgent Genetics, Inc.FLGT - PR Newswire

Jun 22, 2025

Jun 18, 2025

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Fulgent - Bluefield Daily Telegraph

Jun 18, 2025

Jun 16, 2025

GAMMA Investing LLC Acquires 72,261 Shares of Fulgent Genetics, Inc. (NASDAQ:FLGT) - Defense World

Jun 16, 2025

Jun 15, 2025

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Fulgent ... - Bluefield Daily Telegraph

Jun 15, 2025

Jun 11, 2025

UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Buys 5,986 Shares of Fulgent Genetics, Inc. (NASDAQ:FLGT) - Defense World

Jun 11, 2025

Jun 10, 2025

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Fulgent Genetics, Inc. (FLGT) And Encourages Shareholders to Reach Out - ACCESS Newswire

Jun 10, 2025

Bragar Eagel & Squire, P.C. Is Investigating Semler, - GlobeNewswire

Jun 10, 2025

Jun 09, 2025

Bragar Eagel & Squire, P.C. Is Investigating Semler, ADTRAN, and Fulgent and Encourages ... - Bluefield Daily Telegraph

Jun 09, 2025

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Fulgent Genetics, Inc. (FLGT) and Encourages Shareholders to Learn More About the Investigation - ACCESS Newswire

Jun 09, 2025

Jun 08, 2025

Bank of America Corp DE Has $1.48 Million Position in Fulgent Genetics, Inc. (NASDAQ:FLGT) - MarketBeat

Jun 08, 2025